Activation of Cellular Oncogenes in Human and Mouse Leukemia-Lymphomas: Spontaneous and Induced Oncogene Expression in Murine B Lymphocytic Neoplasms

References

• Hayward W., Neel B. C., Astrin S. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 1981; 290: 475–480
   PubMed Web of Science ®Google Scholar
• Potter M., Mushinski J. F. Oncogenes in B cell neoplasia. Cancer Invest 1984; 2: 285–300
   PubMed Web of Science ®Google Scholar
• Bishop J. M. Cellular oncogenes and retroviruses. Ann Rev Biochem 1983; 52: 301–354
   PubMed Web of Science ®Google Scholar
• Hunter T. Oncogenes and proto-oncogenes: how do they differ?. J Natl Cancer Inst 1985; 73: 773–786
   Web of Science ®Google Scholar
• Bishop J. M. Viral oncogenes. Cell 1985; 42: 23–38
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. The action of oncogenes in the cytoplasm and nucleus. Science 1985; 230: 770–776
   PubMed Web of Science ®Google Scholar
• Slamon D. J., de Kernion J. B., Verma I. M., et al. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 256–262
   PubMed Web of Science ®Google Scholar
• Varmus H. E. The molecular genetics of cellular oncogenes. Ann Rev Genet 1984; 18: 553–612
   PubMed Web of Science ®Google Scholar
• Heldin C-H., Westermark B. Growth factors: mechanism of action and relation to oncogenes. Cell 1984; 37: 9–20
   PubMed Web of Science ®Google Scholar
• Doolittle R. F., Hunkapiller M. W., Hood L. E., et al. Simian sarcoma virus one gene, v-sis is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 1983; 221: 275–277
   PubMed Web of Science ®Google Scholar
• Waterfield M. D., Scrace G. T., Whittle N., et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 1983; 304: 35–39
   PubMed Web of Science ®Google Scholar
• Downward J., Yarden Y., Mayes E., et al. Close similarity of epidermal growth factor receptor and v-erb B oncogenic protein sequences, Nature 1984; 307: 521–527
   Google Scholar
• Sherr C. J., Rettenmier C. W., Sacca R., et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor CSF-1. Cell 1985; 41: 665–672
   PubMed Web of Science ®Google Scholar
• Goubin G., Goldman D. S., Luce J., et al. Molecular cloning and nucleotide sequence of a transforming gene detected by transfec-tion of chicken B-cell lymphoma DNA. Nature 1983; 302: 114–119
   PubMed Web of Science ®Google Scholar
• Lane M. A., Sainten A., Doherty K. M., et al. Isolation and characterization of a stage-specific transforming gene, Tlym-l, from T cell lymphomas. Proc Natl Acad Sci (USA) 1984; 81: 2227–2231
   PubMed Web of Science ®Google Scholar
• Rogers J. Relationship of Blym genes to repeated sequences. Nature 1986; 320: 579
   PubMedGoogle Scholar
• Groffen J., Stephenson J. R., Heisterkamp N., et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Yunis J., Onorato-Showe L., et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(ll;14) chromosome translocation. Science 1984; 224: 1403–1406
   PubMed Web of Science ®Google Scholar
• Pegoraro L., Palumbo A., Erikson J., et al. A 14; 18 and an 8; 14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci (USA) 1984; 81: 7166–7170
   PubMed Web of Science ®Google Scholar
• Nusse R., van Ooyen A., Cox D., et al. Modeof proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 1984; 307: 131–136
   PubMed Web of Science ®Google Scholar
• Peters G., Brookes S., Smith R., et al. Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell 1983; 33: 369–377
   PubMed Web of Science ®Google Scholar
• Selten G., Cuypers H. T., Berns A. Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J 1985; 4: 1793–1798
   PubMed Web of Science ®Google Scholar
• Crawford L. V. The 53,000-dalton cellular protein and its role in transformation. Int Rev Exp Pathol 1983; 25: 1–50
   PubMedGoogle Scholar
• Wolf D., Admon S., Aron M., et al. Abelson murine leukemia virus transformed cells that lack p53 protein synthesis express aberrant p53 RNA species. Mol Cell Biol 1984; 4: 552–558
   PubMed Web of Science ®Google Scholar
• Parada L. F., Land H., Weinberg R. A., et al. Cooperation between gene encoding p53 tumour antigen and ras in p53 cellular transformation. Nature 1984; 312: 649–651
   PubMed Web of Science ®Google Scholar
• Wolf D., Harris N., Rotter V. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell 1984; 38: 119–126
   PubMed Web of Science ®Google Scholar
• Cooper C. M., Neiman P. E. Transforming genes of neoplasms induced by avian lymphoid leukosis viruses. Nature 1980; 287: 656–659
   PubMed Web of Science ®Google Scholar
• Cory S. Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res 1986; 47: 189–234
   PubMed Web of Science ®Google Scholar
• Brodeur G. M., Seeger R. C., Schwab M., et al. Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage. Science 1984; 224: 1121–1124
   PubMed Web of Science ®Google Scholar
• Schwab M., Ramsay G., Alitalo K., et al. Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells. Nature 1985; 315: 345–347
   PubMed Web of Science ®Google Scholar
• Little C. D., Nau M. M., Carney D. N., et al. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983; 306: 194–196
   PubMed Web of Science ®Google Scholar
• Kozbor D., Croce C. M. Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. Cancer Res 1984; 44: 438–441
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Wong-Staal F., Gallo R. C. onc gene amplification in promyelocyte leukemia line HL-60 and primary leukaemic cells of the same patient. Nature 1982; 299: 61–63
   PubMed Web of Science ®Google Scholar
• Collins S., Groudine M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 1982; 298: 679–681
   PubMed Web of Science ®Google Scholar
• Wirschubsky Z., Wiener F., Spira J., et al. Triplication of one chromosome no. 15 with an altered c-myc containing EcoRI fragment and elimination of the normal homologue in a T-cell lymphoma line of AKR origin (TIKAUT). Int J Cancer 1984; 33: 477–481
   PubMed Web of Science ®Google Scholar
• Sumegi J., Hedberg T., Bjorkholm M., et al. Amplification of the c-myc oncogene in human plasma-cell luekemia. Int J Cancer 1985; 36: 367–371
   PubMed Web of Science ®Google Scholar
• Cooper G. M., Lane M-A. Cellular transforming genes and oncogenesis. Biochim Biophys Acta 1984; 738: 9–20
   PubMed Web of Science ®Google Scholar
• Tabin C. J., Bradley J. M., Bergmann C. I., et al. Mechanism of activation of a human oncogene. Nature 1982; 300: 143–149
   PubMed Web of Science ®Google Scholar
• Reddy E. P., Reynolds R. K., Santos E., et al. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 1982; 300: 149–152
   PubMed Web of Science ®Google Scholar
• Schwab M., Alitalo K., Varmus H. E., et al. A cellular oncogene (c-Ki-ras) is amplified, overexpressed and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature 1983; 303: 497–501
   PubMed Web of Science ®Google Scholar
• Shen-Ong G. L. C., Keath E., Piccoli S. P., et al. Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell 1982; 31: 443–452
   PubMed Web of Science ®Google Scholar
• Mushinski J. F., Bauer S. R., Potter M., et al. Increased expression of myc-related oncogene messenger RNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus. Proc Natl Acad Sci (USA) 1983; 80: 1073–1077
   PubMed Web of Science ®Google Scholar
• Sumegi J., Spira J., Bazin H., et al. Rat c-myc oncogene is located on chromosome 7 and rearranges in immunocytomas with t(6;7) chromosomal translocation. Nature 1983; 306: 497–498
   PubMed Web of Science ®Google Scholar
• Erikson J., Ar-Rushdi A., Drwinga H. L., et al. Transcriptional activation of the translocated c-myc oncogene in Burkitt lymphoma. Proc Natl Acad Sci (USA) 1983; 80: 820–824
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Martinotti S., Gallo R. C., et al. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 1983; 219: 963–967
   PubMed Web of Science ®Google Scholar
• Klein G. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell 1983; 32: 311–315
   PubMed Web of Science ®Google Scholar
• Kelly K., Siebenlist U. The role of c-myc in the proliferation of normal and neoplastic cells. J Clin Immunol 1985; 5: 65–77
   PubMedGoogle Scholar
• Maguire R. T., Robins T. S., Thorgeirsson S. S., et al. Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types. Proc Natl Acad Sci (USA) 1983; 80: 1947–1950
   PubMed Web of Science ®Google Scholar
• Roy-Burman P., Devi B. G., Parker J. W. Differential expression of c-erb B, c-myc and c-myb oncogene loci in human lymphomas and leukemias. Int J Cancer 1983; 32: 185–191
   PubMed Web of Science ®Google Scholar
• Chinsky J., Lilly F., Childs G. Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc of c-myb. Proc Natl Acad Sci (USA) 1985; 82: 565–569
   PubMed Web of Science ®Google Scholar
• Baba T. W., Giroir B. P., Humphries E. H. Cell lines derived from avian lymphomas exhibit two distinct phenotypes. Virology 1985; 144: 139–151
   PubMed Web of Science ®Google Scholar
• Hayflick J., Seeburg P. H., Ohlsson R., et al. Nucleotide sequence of two overlapping myc-related genes in avian carcinoma verus OK10 and their relation to the myc genes of other viruses and the cell. Proc Natl Acad Sci (USA) 1985; 82: 2718–2722
   PubMed Web of Science ®Google Scholar
• Taub R., Moulding C., Battey J., et al. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 1984; 36: 339–348
   PubMed Web of Science ®Google Scholar
• Yang J-Q., Bauer S. R., Mushinski J. F., et al. Chromosomal translocations clustered 5′ of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J 1985; 4: 1441–1447
   PubMed Web of Science ®Google Scholar
• Remmers E. F., Yang J-Q., Marcu K. B. A negative transcriptional control element located upstream of the murine c-myc gene. EMBO J 1986; 5: 899–904
   PubMed Web of Science ®Google Scholar
• Chung J., Sinn E., Reed R. R., Leder P. Transacting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells. Proc Natl Acad Sci (USA) 1986; 83: 7918–7922
   PubMed Web of Science ®Google Scholar
• Gelman E. P., Psallidopoulos M. C., Papas T. S., et al. Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin mu locus in a Burkitt lymphoma. Nature 1983; 306: 799–803
   PubMed Web of Science ®Google Scholar
• Corcoran L. M., Cory S., Adams J. M. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma. Cell 1985; 40: 71–79
   PubMed Web of Science ®Google Scholar
• Fahrlander P. D., Sumegi J., Yang J-Q., et al. Activation of the c-myc oncogene by the immunoglobulin heavy-chain enhancer after multiple switch region mediated chromosome rearrangements in a murine plasmacytoma. Proc Natl Acad Sci (USA) 1985; 82: 3746–3750
   PubMed Web of Science ®Google Scholar
• Bernard O., Cory S., Gerondakis S., et al. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J 1983; 2: 2375–2383
   PubMed Web of Science ®Google Scholar
• Ar-Rushdi A., Nishikura K., Erikson J., et al. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 1983; 222: 390–393
   PubMed Web of Science ®Google Scholar
• Croce C. M., Erikson J., Ar-Rushdi A., et al. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. Proc Natl Acad Sci (USA) 1984; 81: 3170–3174
   PubMed Web of Science ®Google Scholar
• Feo S., Ar-Rushdi A., Heubner K., et al. Suppression of the normal mouse c-myc oncogene in human lymphoma cells. Nature 1985; 313: 493–495
   PubMed Web of Science ®Google Scholar
• Nishikura K., Ar-Rushdi A., Erikson J., et al. Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids. Science 1984; 224: 399–402
   PubMed Web of Science ®Google Scholar
• Croce C. M., Erikson J., Huebner K., et al. Coexpression of translocated and normal c-myc oncogenes in hybrids between Daudi and lymphoblastoid cells. Science 1985; 227: 1235–1238
   PubMed Web of Science ®Google Scholar
• Cory S., Graham M., Webb E., et al. Variant (6; 15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J 1985; 4: 675–681
   PubMed Web of Science ®Google Scholar
• Erikson J., Nishikura K., Ar-Rushdi A., et al. Translocation of an immunoglobulin kappa locus to a region 3′ of an unrearranged c-myc oncogene enhances c-myc transcription. Proc Natl Acad Sci (USA) 1983; 80: 7581–7585
   PubMed Web of Science ®Google Scholar
• Hollis G. F., Mitchell K. F., Battey J., et al. A variant translocation places the lambda immunoglobulin genes 3′ to the c-myc oncogene in Burkitt's lymphoma. Nature 1984; 307: 752–755
   PubMed Web of Science ®Google Scholar
• Payne G. S., Bishop J. M., Varmus H. E. Multiple arrangements of viral DNA and an activated host oncogene (c-myc) in bursal lymphomas. Nature 1982; 295: 209–217
   PubMed Web of Science ®Google Scholar
• Graham M., Adams J. M., Cory S. Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature 1985; 314: 740–743
   PubMed Web of Science ®Google Scholar
• Corcoran L. M., Adams J. M., Dunn A. R., et al. Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell 1984; 37: 113–122
   PubMed Web of Science ®Google Scholar
• Steffen D. Proviruses are adjacent to c-myc in some murine leukemia virus-induced lymphomas. Proc Natl Acad Sci (USA) 1984; 81: 2097–2101
   PubMed Web of Science ®Google Scholar
• Cuypers H. T., Selten G., Quint W., et al. Murine leukemia virus-induced T cell lymphomagenesjs: integration of proviruses in a distinct chromosomal region. Cell 1984; 37: 141–150
   PubMed Web of Science ®Google Scholar
• Selten G., Cuypers H. T., Zijlstra M., et al. Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J 1984; 3: 3215–3222
   PubMed Web of Science ®Google Scholar
• Li Y., Holland C. A., Hartley J. W., et al. Viral integration near c-myc in 10–20% of MCF247-induced AKR lymphomas. Proc Natl Acad Sci (USA) 1984; 81: 6808–6811
   PubMed Web of Science ®Google Scholar
• Romberg P. G., Erisman M. D., Diehl R. E., et al. Structure and expression of the oncogene c-myc in fresh tumor material from patients with hematopoietic malignancies. Mol Cell Biol 1984; 4: 1096–1103
   PubMed Web of Science ®Google Scholar
• Linial M., Gunderson N., Groudine M. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science 1985; 230: 1126–1132
   PubMed Web of Science ®Google Scholar
• Einat M., Resnitzky D., Kimchi A. Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 1985; 313: 597–600
   PubMed Web of Science ®Google Scholar
• Knight E., Jr, Anton E. D., Fahey D., et al. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc Natl Acad Sci (USA) 1985; 82: 1151–1154
   PubMed Web of Science ®Google Scholar
• Matsui T., Takahashi R., Mihara K., et al. Cooperative regulation of c-myc expression in differentiation of human promyelocytic leukemia induced by recombinant gamma-interferon and 1,25-dihydroxy vitamin D3. Cancer Res 1985; 45: 4366–4371
   PubMed Web of Science ®Google Scholar
• Kelly K., Cochran B. H., Stiles C. D., et al. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 1983; 35: 603–610
   PubMed Web of Science ®Google Scholar
• McCormack J. E., Pepe V. H., Kent R. B., et al. Specific regulation of c-myc oncogene expression in a murine B cell lymphoma. Proc Natl Acad Sci (USA) 1984; 81: 5546–5550
   PubMed Web of Science ®Google Scholar
• Armelin H. A., Armelin M. C. S., Kelly K., et al. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 1984; 310: 655–660
   PubMed Web of Science ®Google Scholar
• Reed J. C., Nowell P. C., Hoover R. G. Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation. Proc Natl Acad Sci (USA) 1985; 82: 4221–4224
   PubMed Web of Science ®Google Scholar
• Reed J. C., Sabath D. E., Hoover R. G., et al. Recombinant interleukin 2 regulates levels of c-myc RNA in a cloned murine T lymphocyte. Mol Cell Biol 1985; 5: 3361–3368
   PubMed Web of Science ®Google Scholar
• Zimmerman K. A., Vancopoulos G. D., Collum R. G., et al. Differential expression of myc family genes during murine development. Nature 1986; 319: 780–783
   PubMed Web of Science ®Google Scholar
• Thompson C. B., Challoner P. B., Neiman P. E., et al. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 1985; 314: 363–366
   PubMed Web of Science ®Google Scholar
• Hann S. R., Thompson C. B., Eisenman R. N. C-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 1985; 314: 366–369
   PubMed Web of Science ®Google Scholar
• Greenberg M. E., Ziff E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 1983; 311: 433–438
   Web of Science ®Google Scholar
• Dani C., Blanchard J. M., Piechaczyk M., et al. Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci (USA) 1984; 81: 7046–7050
   PubMed Web of Science ®Google Scholar
• Piechaczyk M., Yang J. Q., Blanchard J. M., et al. Post-transcriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors. Cell 1985; 42: 589–597
   PubMed Web of Science ®Google Scholar
• Land H., Parada L. F., Weinberg R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983; 304: 596–601
   PubMed Web of Science ®Google Scholar
• Lee W. M. F., Schwab M., Westaway D., et al. Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells wth a mutant ras gene. Mol Cell Biol 1985; 5: 3345–3356
   PubMed Web of Science ®Google Scholar
• Keath E. J., Caimi P. G., Cole M. D. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell 1984; 39: 339–348
   PubMed Web of Science ®Google Scholar
• Palmieri S., Kahn P., Graf T. Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic. EMBO J 1983; 2: 2385–2389
   PubMed Web of Science ®Google Scholar
• Neiman P., Wolf C., Enrietto P. J., et al. A retroviral myc gene induces preneoplastic transformation of lymphocytes in a bursal transplantation assay. Proc Natl Acad Sci (USA) 1985; 82: 222–226
   PubMed Web of Science ®Google Scholar
• Klein G., Klein E. Oncogene activation and tumor progression. Carcinogenesis 1984; 5: 429–435
   PubMed Web of Science ®Google Scholar
• Yokota J., Tsunetsugu-Yokota Y., Baltitora H., et al. Alterations of myc, myb and rasHa protooncogenes in cancers are frequent and show clinical correlation. Science 1986; 231: 261–265
   PubMed Web of Science ®Google Scholar
• Duesberg P. H. Activated proto-onc genes: sufficient or necessary for cancer?. Science 1985; 228: 669–677
   PubMed Web of Science ®Google Scholar
• Rosenberg N., Baltimore D. Abelson virus. Viral Oncol 1980; 1: 187–203
   Google Scholar
• Serunian L. A., Rosenberg N. Abelson virus potentiates long-term growth of mature B lymphocytes. Mol Cell Biol 1986; 6: 183–194
   PubMed Web of Science ®Google Scholar
• Potter M., Sklar M. D., Rowe W. P. Rapid viral induction of plasmacytomas in pristane-primed BALB/c mice. Science 1973; 182: 592–594
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., et al. Fused transcript of abl and brc genes in chronic myelogenous leukaemia. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stam K., Groffen J., et al. Structural organization of the bcr gene and its role in the Ph1 translocation. Nature 1985; 315: 758–761
   PubMed Web of Science ®Google Scholar
• Collins S. I., Kubonishi I., Miyoshi I., et al. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science 1984; 225: 72–74
   PubMed Web of Science ®Google Scholar
• Konopka J. B., Watanabe S. M., Witte O. N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035–1042
   PubMed Web of Science ®Google Scholar
• Collins S. J., Groudine M. T. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci (USA) 1983; 80: 4813–4817
   PubMed Web of Science ®Google Scholar
• Bartram C. R., Kleihauer E., De Klein A., et al. C-abl and bcr are rearranged in Ph1-negative CML patient. EMBO J 1985; 4: 683–686
   PubMed Web of Science ®Google Scholar
• Konopka J. B., Clark S., McLaughlin J., et al. Variable expression of the translocated c-abl gene in Ph1-positive B-lymphoid cell lines from chronic myelogenous leukemic patients. Proc Nad Acad Sci (USA) 1986; 83: 4049–4052
   PubMed Web of Science ®Google Scholar
• Westin E., Wong-Staal F., Gelmann E. P., et al. Expression of cellular homologues of retroviral one genes in human hematopoietic cells. Proc Natl Acad Sci (USA) 1982; 79: 2490–2494
   PubMed Web of Science ®Google Scholar
• Clarke M. F., Westin E., Schmidt D., et al. Transformation of NIH 3T3 cells by a human c-sis cDNA clone. Nature 1984; 308: 464–467
   PubMed Web of Science ®Google Scholar
• Chinsky J., Lilly F., Childs G. Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb. Proc Natl Acad Sci (USA) 1985; 82: 565–569
   PubMed Web of Science ®Google Scholar
• Mally M. I., Vogt M., Swift S. E., et al. Oncogene expression in murine splenic T cells and in murine T-cell neoplasms. Virology 1985; 144: 115–126
   PubMed Web of Science ®Google Scholar
• Eva A., Robbins K. C., Andersen P. R., et al. Cellular genes analogous to retroviral one genes are transcribed in human tumour cells. Nature 1982; 295: 116–119
   PubMed Web of Science ®Google Scholar
• Winberry L., Priehs C., Friderici K., et al. Expression of protooncogenes in normal and papovavirus-transformed or -infected rat fibroblasts. Virology 1985; 147: 154–168
   PubMed Web of Science ®Google Scholar
• Woolford J., Rothwell V., Rohrschneider L. Characterization of the human c-fins gene product and its expression in cells of the monocyte-macrophage lineage. Mol Cell Biol 1985; 5: 3458–3466
   PubMed Web of Science ®Google Scholar
• LeBeau M. M., Westbrook C. A., Diaz M. O., et al. Evidence for the involvement of GM-CSF and fins in the deletion (5q) in myeloid disorders. Science 1986; 231: 984–987
   PubMed Web of Science ®Google Scholar
• Rosson D., Tereba A. Transcription of hematopoietic-associated oncogenes in childhood leukemia. Cancer Res 1983; 43: 3912–3918
   PubMed Web of Science ®Google Scholar
• Pierce J., Gazit A., DiFióre P. P., et al. Mammalian cell transformation by a recombinant murine retrovirus containing the avian erythroblastosis virus erb B gene. Curr Top Micro Immunol 1986; 132: 55–61
   PubMed Web of Science ®Google Scholar
• Blick M., Westin E., Gutterman J., et al. Oncogene expression in human leukemia. Blood 1984; 64: 1234–1239
   PubMed Web of Science ®Google Scholar
• Coll J., Saule S., Martin P. The cellular oncogenes c-myc, c-myb and c-erb are transcribed in defined types of avian hematopoietic cells. Exp Cell Res 1983; 149: 151–162
   PubMed Web of Science ®Google Scholar
• Rosson D., Tereba A. Transcription of hematopoietic associated oncogenes in childhood leukemia. Cancer Res 1983; 43: 3912–3918
   PubMed Web of Science ®Google Scholar
• Sheiness D., Gardinier M. Expression of a proto-oncogene (proto-myb) in hemopoietic tissues of mice. Mol Cell Biol 1984; 4: 1206–1212
   PubMed Web of Science ®Google Scholar
• Ferrari S., Torelli U., Selleri L., et al. Study of the levels of expression of two oncogenes, c-myc and c-myb, in acute and chronic leukemias of both lymphoid and myeloid lineage. Leuk Res 1985; 9: 833–842
   PubMed Web of Science ®Google Scholar
• Pelicci P-G., Lanfrancone L., Brathwaite M. D., et al. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 1984; 224: 1117–1121
   PubMed Web of Science ®Google Scholar
• Griffin C. A., Baylin S. B. Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res 1985; 45: 272–275
   PubMed Web of Science ®Google Scholar
• Alitalo K., Winquist R., Liu C. C., et al. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc Natl Acad Sci (USA) 1984; 81: 4534–4538
   PubMed Web of Science ®Google Scholar
• Mushinski J. F., Potter M., Bauer S. R., et al. DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science 1983; 220: 795–798
   PubMed Web of Science ®Google Scholar
• Shen-Ong G. L. C., Potter M., Mushinski J. F., et al. Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science 1984; 226: 1077–1080
   PubMed Web of Science ®Google Scholar
• Shen-Ong G. L. C., Morse H. C., III, Potter M., et al. Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol 1986; 6: 380–392
   PubMed Web of Science ®Google Scholar
• Torelli G., Selleri L., Donelli A., et al. Activation of c-myb expression by phytohemagglutinin stimulation in normal human T lymphocytes. Mol Cell Biol 1985; 5: 2874–2877
   PubMed Web of Science ®Google Scholar
• Thompson C. B., Challoner P. B., Neiman P. E., et al. Expression of the c-myb proto-oncogene during cellular proliferation. Nature 1986; 319: 374–380
   PubMed Web of Science ®Google Scholar
• Klinman D. M., Mushinski J. F., Honda M., et al. Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med 1986; 163: 1292–1307
   PubMed Web of Science ®Google Scholar
• Seldin M. F., Mountz J. D., Mushinski J. F., et al. IL-2 modulation of murine T-cell oncogene expression. Proc Soc Exp Biol Med 1987; 184: 186–190
   PubMed Web of Science ®Google Scholar
• Gonda T. J., Metcalf D. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 1984; 310: 249–251
   PubMed Web of Science ®Google Scholar
• Craig R. W., Bloch A. Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1984; 44: 442–446
   PubMed Web of Science ®Google Scholar
• Tabin C. J., Weinberg R. A. Analysis of viral and somatic activations of the cHa-ras gene. J Virol 1985; 53: 260–265
   PubMed Web of Science ®Google Scholar
• Bos J. L., Verlaan-de Vries M., Jansen A. M., et al. Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucleic Acids Res 1984; 12: 9155–9163
   PubMed Web of Science ®Google Scholar
• McGrath J. P., Capon D. J., Goeddel D. V., et al. Comparative biochemical properties of normal and activated human ras p21 protein. Nature 1984; 310: 644–649
   PubMed Web of Science ®Google Scholar
• Murray M. J., Cunningham J. M., Parada L. F., et al. The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell 1983; 33: 749–757
   PubMed Web of Science ®Google Scholar
• Souyri I. M., Fleissner E. Identification by transfection of transforming sequences in DNA of human T-cell leukemias. Proc Natl Acad Sci (USA) 1983; 80: 6676–6679
   PubMed Web of Science ®Google Scholar
• Eva A., Tronick S. R., Gol R. A., et al. Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proc Natl Acad Sci (USA) 1983; 80: 4926–4930
   PubMed Web of Science ®Google Scholar
• Collard J. G., van Beek W. P., Janssen J. W. G., et al. Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations. Int J Cancer 1985; 35: 207–214
   PubMed Web of Science ®Google Scholar
• Gambke C., Signer E., Moroni C. Activation of N-ras gene in bone marrow cells from a patient with acute myeloblastic leukaemia. Nature 1984; 307: 476–478
   PubMed Web of Science ®Google Scholar
• Gambke C., Hall A., Moroni C. Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon. Proc Natl Acad Sci (USA) 1985; 82: 879–882
   PubMed Web of Science ®Google Scholar
• Bos J. L., Toksoz D., Marshall C. J., et al. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 1985; 315: 726–730
   PubMed Web of Science ®Google Scholar
• Guerrero I., Calzada P., Mayer A., et al. A molecular approach to leukemogenesis: mouse lymphomas contain an activated c-ras oncogene. Proc Natl Acad Sci (USA) 1984; 81: 202–205
   PubMed Web of Science ®Google Scholar
• Guerrero I., Villasante A., Corces V., et al. Activation of a c-K-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation. Science 1984; 225: 1159–1162
   PubMed Web of Science ®Google Scholar
• Vousden K. H., Marshall C. J. Three different activated ras genes in mouse tumours: evidence for oncogene activation during progression of a mouse lymphoma. EMBO J 1984; 3: 913–917
   PubMed Web of Science ®Google Scholar
• Yoakum G. H., Lechner J. F., Gabrielson E. W., et al. Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene. Science 1985; 227: 1174–1179
   PubMed Web of Science ®Google Scholar
• Blick M., Westin E., Gutterman J., et al. Oncogene expression in human leukemia. Blood 1984; 64: 1234–1239
   PubMed Web of Science ®Google Scholar
• Spandidos D. A., Wilkie N. M. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 1984; 310: 469–475
   PubMed Web of Science ®Google Scholar
• Pulciani S., Santos E., Long L. K., et al. ras gene amplification and malignant transformation. Mol Cell Biol 1985; 5: 2836–2841
   PubMed Web of Science ®Google Scholar
• Holmes K. L., Pierce J. H., Davidson W. S., Morse H. C., III. Murine hematopoietic cells with pre-B/myeloid characteristics are generated by in vitro transformation with retrovirus containing fes, abl, and src oncogenes. J Exp Med 1986; 164: 443–457
   PubMed Web of Science ®Google Scholar
• Diamond A., Devine J. M., Cooper G. M. Nucleotide sequence of a human Blym transforming gene activated in a Burkitt's lymphoma. Science 1984; 225: 516–519
   PubMed Web of Science ®Google Scholar
• Eva A., Aaronson S. A. Isolation of a new human oncogene from a diffuse B-cell lymphoma. Nature 1985; 316: 273–275
   PubMed Web of Science ®Google Scholar
• Takahashi M., Ritz J., Cooper G. M. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985; 42: 581–588
   PubMed Web of Science ®Google Scholar
• Canaani E., Dreazen O., Klar A., et al. Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci (USA) 1983; 80: 7118–7122
   PubMed Web of Science ®Google Scholar
• Gattoni-Celli S., Hsiao W-L. W., Weinstein I. B. Rearranged c-mos locus in a MOPC21 murine myeloma cell line and its persistence in hybridomas. Nature 1983; 306: 795–796
   PubMed Web of Science ®Google Scholar
• Propst F., van de Woude G. F. Expression of c-mos proto-oncogene transcripts in mouse tissues. Nature 1985; 315: 516–518
   PubMed Web of Science ®Google Scholar
• Diaz M. O., LeBeau M. M., Rowley J. D., et al. The role of the c-mos gene in the 8;21 translocation in human acute myeloblastic leukemia. Science 1985; 229: 767–769
   PubMed Web of Science ®Google Scholar
• Revoltella R. P., Park M., Fruscalzo A. Identification in several human myeloid leukemias or cell lines of a DNA rearrangement next to the c-mos 3′-end. FEBS Lett 1985; 189: 97–101
   PubMed Web of Science ®Google Scholar
• Yunis J. J. The chromosomal basis of human neoplasia. Science 1983; 221: 227–236
   PubMed Web of Science ®Google Scholar
• Rowley J. D. Biological implications of consistent chromosome rearrangements in leukemia and lymphoma. Cancer Res 1984; 44: 3159–3168
   PubMed Web of Science ®Google Scholar
• Pearson M., Rowley J. D. The relation of oncogenesis and cytogenetics in leukemia and lymphoma. Ann Rev Med 1985; 36: 471–483
   PubMed Web of Science ®Google Scholar
• Yunis J. J. Fragile sites and predisposition to leukemia and lymphoma. Cancer Genet Cytogenet 1984; 12: 85–88
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Cossman J., Jaffe E., et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–1443
   PubMed Web of Science ®Google Scholar
• Bakhshi A., Jensen J. P., Goldman P., et al. Cloning the chromosomal breakpoint of t(14; 18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899–906
   PubMed Web of Science ®Google Scholar
• Garfinkel N., Unger T., Girol D., Mushinski J. F. Expression of the bcl-2 gene in mouse B lymphocytic lines is differentiation stage specific. Eur J Immunol 1987; 17: 567–570
   PubMed Web of Science ®Google Scholar
• van Beveren C., van Straaten F., Curran T., et al. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 1983; 32: 1241–1255
   PubMed Web of Science ®Google Scholar
• Mueller R., Mueller D., Guilbert L. Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO I 1984; 3: 1887–1890
   PubMed Web of Science ®Google Scholar
• Mitchell R. L., Zokas L., Schreiber R. D., et al. Rapid induction of the expression of proto-oncogene fos during human monocyte differentiation. Cell 1985; 40: 209–217
   PubMed Web of Science ®Google Scholar
• Ferrari S., Torelli U., Selleri L., et al. Expression of human c-fesone-gene occurs at detectable levels in myeloid but not in lymphoid cell population. Br J Haematol 1985; 59: 21–25
   PubMed Web of Science ®Google Scholar
• Sariban E., Mitchell T., Kufe D. Expression of the c-fins proto-oncogene during human monocytic differentiation. Nature 1985; 316: 64–66
   PubMed Web of Science ®Google Scholar
• Shen-Ong G. L. C., Holmes K. L., Morse H. C., III. Phorbol ester-induced growth arrest of murine myelomonocytic leukemia cells with virus-disrupted myb locus is not accompanied by decreased myc and myb expression. Proc Natl Acad Sci (USA) 1987; 84: 199–203
   PubMed Web of Science ®Google Scholar
• Eliyahu D., Raz A., Gruss P., et al. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 1984; 312: 646–649
   PubMed Web of Science ®Google Scholar
• Rogel A., Popliker M., Webb C. G., et al. P53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos and tumors. Mol Cell Biol 1985; 5: 1851–1855
   Google Scholar
• Leprince D., Gegonne A., Coll J., et al. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 1983; 306: 395–397
   PubMed Web of Science ®Google Scholar
• Rovigatti U., Watson D., Yunis J. J. Amplification and rearrangement of Hu-ets-1 in leukemia and lymphoma with involvement of llq23. Science 1986; 232: 398–400
   PubMed Web of Science ®Google Scholar
• Chen J. H. The proto-oncogene c-ets is preferentially expressed in lymphoid cells. Mol Cell Biol 1983; 5: 2993–3000
   Web of Science ®Google Scholar
• Rosenberg Y. J., Malek T. R., Schaeffer D. E., et al. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-Ipr/Ipr mice. J Immunol 1985; 134: 3120–3123
   PubMed Web of Science ®Google Scholar
• Mountz J. D., Mushinski J. F., Mark G. E., et al. Oncogene expression and auto-immunity. J Mol Cell Immunol 1985; 2: 121–131
   PubMedGoogle Scholar
• Erikson J., Miller D. A., Miller O. J., et al. The c-myc oncogene is translocated to the involved chromosome 12 in mouse plasmacytoma. Proc Natl Acad Sci (USA) 1985; 82: 4212–4216
   PubMed Web of Science ®Google Scholar
• Groffen J., Heisterkamp N., Stephenson J. R., et al. C-sis is translocated from chromosome 22 to chromosome 9 in chronic myelogenous leukemia. J Exp Med 1983; 158: 9–15
   PubMed Web of Science ®Google Scholar
• Clarke M. F., Westin E., Schmidt D., et al. Transformation of NIH 3T3 cells by a human c-sis cDNA clone. Nature 1984; 308: 464–467
   PubMed Web of Science ®Google Scholar
• Kincade P. W. Formation of B lymphocytes in fetal and adult life. Adv Immunol 1981; 31: 177–245
   PubMed Web of Science ®Google Scholar
• Coffman R. L. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol Rev 1982; 69: 5–23
   PubMed Web of Science ®Google Scholar
• Davidson W. F., Frederickson T. N., Rudikoff E. K., et al. A unique series of lymphomas related to the Ly-1+ lineage of B lymphocyte differentiation. J Immunol 1984; 133: 744–753
   PubMed Web of Science ®Google Scholar
• Holmes K. L., Palfree R. G. E., Hammerling U., et al. Alleles of the Ly-17 alloantigen define polymorphisms of the murine IgG Fc receptor. Proc Natl Acad Sci (USA) 1985; 82: 7706–7710
   PubMed Web of Science ®Google Scholar
• Coffman R. L., Weissman I. L. B220: a B cell-specific member of the T200 glycoprotein family. Nature 1981; 289: 681–683
   PubMed Web of Science ®Google Scholar
• Symington F. W., Subbarao B., Mosier D. E., et al. Lyb-8.2: a new B cell antigen defined and characterized with a monoclonal an tibody. Immunogenetics 1982; 16: 381–391
   PubMed Web of Science ®Google Scholar
• Osmond D. G., Nossal G. J. V. Differentiation of lymphocytes in mouse bone marrow. II. Kinetics of maturation and renewal of antiglobulin-binding cells studied by double labelling. Cell Immunol 1974; 13: 132–141
   PubMed Web of Science ®Google Scholar
• Osmond D. G. Generation of B lymphocytes in bone marrow. B Lymphocytes in the Immune Response, M. Cooper, D. E. Mosier, I. Scher, E. Vitetta. Elsevier-North Holland, New York 1979; 65–66
   Google Scholar
• Pattengale P. K., Taylor C. R. Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. Am J Pathol 1983; 113: 237–265
   PubMed Web of Science ®Google Scholar
• Fredrickson T. N., Morse H. C., III, Yetter R. A., et al. Multiparameter analysis of spontaneous non-thymic lymphomas occurring in NFS/N mice congenic for ecotropic murine leukemia viruses. Am J Pathol 1985; 121: 349–360
   PubMed Web of Science ®Google Scholar
• Paige C. J., Kincade P. W., Ralph P. Murine B cell leukemia line with inducible surface immunoglobulin expression. J Immunol 1978; 121: 641–647
   PubMed Web of Science ®Google Scholar
• Hardy R. R., Herzenberg L. A., Morse H. C., III, et al. Ly-1 as a differentiation antigen on normal and neoplastic B cells. Curr Top Micro Immunol 1984; 113: 231–236
   PubMed Web of Science ®Google Scholar
• Pierce J. H., Aaronson S. A. BALB- and Harvey-murine sarcoma virus transformation of a novel lymphoid progenitor cell. J Exp Med 1982; 156: 873–887
   PubMed Web of Science ®Google Scholar
• Piechaczyk M., Blanchard J-M., Marty L., et al. Post-transcriptional regulation of glyceraldehyde dehydrogenase gene expression in rat tissues. Nucleic Acids Res 1984; 12: 6951–6963
   PubMed Web of Science ®Google Scholar
• Rapp U., Cleveland J. L., Fredrickson T. N., et al. Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus. J Virol 1985; 55: 23–33
   PubMed Web of Science ®Google Scholar
• Risser R., Potter M., Rowe W. P. Abelson virus-induced lymphomagenesis in mice. J Exp Med 1978; 148: 714–726
   PubMed Web of Science ®Google Scholar
• Alt F., Rosenberg N., Lewis S., et al. Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: rearrangement of heavy but not light chain genes. Cell 1981; 27: 381–390
   PubMed Web of Science ®Google Scholar
• Raschke W. C., Baird S., Ralph P., et al. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978; 15: 261–267
   PubMed Web of Science ®Google Scholar
• Risser R. The pathogenesis of Abelson virus lymphomas of the mouse. Biochim Biophys Acta 1982; 651: 213–244
   PubMed Web of Science ®Google Scholar
• Langdon W. Y., Hartley J. W., Holmes K. L., et al. Identification of a transforming virus from a lymphoma of a mouse infected with a wild mouse retrovirus. Curr Top Micro Immunol 1984; 113: 421–429
   Google Scholar
• Holmes K. L., Landgon W. Y., Frederickson T. N., et al. Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts. J Immunol 1986; 137: 679–688
   PubMed Web of Science ®Google Scholar
• Teich N., Wyke J., Mak T., . Pathogenesis of retrovirus-induced disease. RNA Tumor Viruses. Molecular Biology of Tumor Viruses second edition, R. Weiss, N. Teich, H. Varmus, J. Coffin, et al. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1982; 785–998
   Google Scholar
• Morse H. C., III, Hartley J. W., Fredrickson T. N., et al. Recombinant murine retrovirus containing avian V-myc induce a wide spectrum of neoplasms in newborn mice. Proc Natl Acad Sci (USA) 1986; 83: 6868–6872
   PubMed Web of Science ®Google Scholar
• Potter M., Mushinski J. F., Mushinski E. B., et al. Avian V-myc replaces chromosomal translocation in murine plasmacytoma genesis. Science 1987; 235: 787–789
   PubMed Web of Science ®Google Scholar
• Anderson S. M., Scolnick E. M. Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus. J Virol, 46: 594–605
   PubMed Web of Science ®Google Scholar
• Rosenberg N., Baltimore D. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J Exp Med 1976; 143: 1453–1463
   PubMed Web of Science ®Google Scholar
• Rosenberg N. E. Abelson leukemia virus. Curr Top Micro Immunol 1982; 101: 95–126
   PubMed Web of Science ®Google Scholar
• Pierce J. H., Aaronson S. A. In vitro transformation of murine pre-B lymphoid cells by Snyder-Theilen feline sarcoma virus. J Virol 1983; 46: 993–1002
   PubMed Web of Science ®Google Scholar
• Pierce J. H., Aaronson S. A., Anderson S. M. Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus. Proc Natl Acad Sci (USA) 1984; 81: 2374–2378
   PubMed Web of Science ®Google Scholar
• Pierce J. H., Aaronson S. A. Myeloid cell transformation by ras-containing murine sarcoma viruses. Mol Cell Biol 1985; 5: 667–674
   PubMed Web of Science ®Google Scholar
• Stewart T. A., Pattengale P. K., Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984; 38: 627–637
   PubMed Web of Science ®Google Scholar
• Adams J. M., Harris A. W., Pinkert C. A., et al. C-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533–538
   PubMed Web of Science ®Google Scholar
• Pattengale P., Leder A., Kuo A., et al. Lymphohematopoietic and other malignant neoplasms occurring spontaneously in transgenic mice carrying and expresing MTV/myc fusion genes. Curr Top Micro Immunol 1986; 132: 9–16
   PubMed Web of Science ®Google Scholar
• Schwartz R. C., Stanton L. W., Marcu K. B., et al. An in vitro model for tumor progression in murine lymphoid cells. Curr Top Micro Immunol 1986; 132: 75–80
   PubMed Web of Science ®Google Scholar
• Schrier P. I., Bernards R., Vaessen R. TMJ., et al. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 1983; 305: 771–775
   PubMed Web of Science ®Google Scholar
• Sullivan N., Green C., Pasdar M., Watt R. Characterization and nuclear localization of the v- and c-myc proteins. Curr Top Micro Immunol 1986; 132: 355–361
   PubMed Web of Science ®Google Scholar